2.13 USD
↗ 0.17 (8.62%)PRE MARKET (AS OF 08:01 AM EST)
Shares of Edesa Biotech, Inc. Common Shares (EDSA) are trading at $2.13. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest EDSA is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Nov 18, 2026.